Azacitidine (Vidaza) News, Updated Regularly

RealMoney.com: Pharmaceuticals - Street.Com
October 23, 2008, 7:24 am

Celgene ( CELG - commentary - Cramer's Take ) reported a strong quarter with lots of optimism for the longer-term picture. For the quarter just ended, the company posted EPS of 40 cents on revenue of $587 million. Revlimid sales increased 72%, to ...

Significant Developments: Biotechnology - Reuters
November 8, 2008, 12:57 am

Altus Pharmaceuticals Inc. announced the completion of the last patient visit of the Trizytek Phase 3 efficacy trial. In this trial, Altus is evaluating the efficacy of an oral, non-porcine enzyme replacement therapy for cystic fibrosis patients with ...

EU Panel Backs Wider Approval Of Merck's Erbitux - Wall Street Journal
October 24, 2008, 2:50 am

ZURICH (Dow Jones)--The Committee for Medicinal Products for Human Use of the European Medicines Agency, an advisory panel to the EU drug watchdog adopted positive opinions for the following medicines: * Lunivia (eszopiclone), from Sepracor ...

Cancer Drug Vidaza(R) Receives Positive Opinion from European ... - MSN MoneyCentral
October 24, 2008, 2:43 am

Celgene International S à rl CELG today announced that its cancer drug, VIDAZA ® (azacitidine), has received a positive opinion from the European Medicines Agency ? s Committee for Medicinal Products for Human Use (CHMP) for the treatment ...

Celgene Reports Record Third Quarter 2008 Product Sales and Operating ... - MSN MoneyCentral
October 23, 2008, 4:32 am

VIDAZA Label Expanded to Include Data on Overall Survival in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) Approved by FDA VIDAZA Royalty Obligation Purchased in October 2008 for All Future Periods Optimizing Long-Term Value of VIDAZA ...

The MDS Foundation Supports Vidaza's Recommendation For European ... - Medical News Today
October 27, 2008, 5:56 pm

The Myelodysplastic Syndromes (MDS) Foundation supports the positive opinion from the European Union's Committee for Medicinal Products for Human Use (CHMP) recommending approval of VIDAZA (azacitidine) for specific types of MDS patients, including ...

EMEA Issues Opinions - Phramalive.com
October 22, 2008, 5:55 pm

LONDON, Oct. 23, 2008-The EMEA's Committee for Medicinal Products for Human Use today posted on its website opinions for a number of pharmaceutical products. Links to the opinions are below. Committee for Medicinal Products for Human Use Post ...

Celgene wins CHMP positive opinion for cancer drug - Pharmaceutical Business Review
October 26, 2008, 5:57 pm

Celgene International has announced that its cancer drug, Vidaza, has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for the treatment of adult patients with myelodysplastic syndromes ...

Website shows how Jerseyans spent stimulus checks - Newark Star-Ledger
October 24, 2008, 5:59 pm

Remember those economic stimulus checks the federal government sent taxpayers earlier this year in the months before the Wall Street meltdown? Last week, Federal Reserve Chairman Ben Bernanke urged Congress to consider a second economic stimulus ...

Are you looking for additional Vidaza (Azacitidine) news? Try our new "Azacitidine News Focus" area.

Are you looking for additional Vidaza (Azacitidine) information? Try our new "Azacitidine Related Blog Entries" area.

Off-site Azacitidine (Vidaza) Links, User Submitted

The following links have been collected through user bookmark submission in the Azacitidine_Vidaza category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Off-site Azacitidine Research Links

If you still need additional information on Azacitidine then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.